Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About

Beauty Health Company to Acquire SkinStylus

Published February 28, 2023
Published February 28, 2023

Beauty Health Company, home to flagship brand Hydrafacial, has entered a definitive agreement to acquire SkinStylus, an FDA-cleared microneedling device.

WHO: SkinStylus, the microneedling device, was co-invented by a team of skincare and aesthetics professionals. Microneedling is a nonsurgical procedure using an array of tiny needles to create microscopic punctures in the skin to stimulate the body’s natural wound response, which is associated with the creation of new collagen and, with that, smoother, firmer, and more even-toned skin. The device is categorized by the FDA as a Class II Medical Device.

The Beauty Health Company is a global category-creating company delivering beauty health experiences that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Their flagship brand Hydrafacial created the category of hydradermabrasion by using a patented vortex-fusion delivery system to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Hydrafacial provides a noninvasive and approachable skincare experience available in more than 90 countries with an install base of over 25,000 delivery systems, providing millions of experiences to consumers each year.

WHY: Expected to reach $1 billion in market size by 2030, microneedling is highly complementary to a Hydrafacial treatment and one of the most common co-treatments providers offer. The agreement represents a key step forward in BeautyHealth’s portfolio build-up strategy to achieve its vision of becoming the world’s leading beauty, health, and wellness platform.

IN THEIR OWN WORDS: “Our long-held vision for BeautyHealth is to build an interconnected platform of brands and services that answer the booming consumer demand for seamless access to beauty health experiences and that support our community of estheticians and providers in delivering amazing services,” said BeautyHealth President and Chief Executive Officer Andrew Stanleick. “SkinStylus is a best-in-class microneedling device and, as an esthetician-founded brand, is grounded in real world insights from the treatment room. We are excited to roll out SkinStylus broadly to our Hydrafacial Nation.”

“Microneedling is an exciting advancement in aesthetics that offers a minimally invasive treatment option with little downtime to improve the overall appearance of skin. It is the most requested treatment option from the tens of thousands of providers we work with around the world,” said BeautyHealth Chief Medical Officer Dr. Jwala Karnik. “Having carefully studied the category, we believe SkinStylus is new, better and different to anything else on the market. We are pleased to add SkinStylus to our portfolio and to build on our science-backed treatment offerings.”


  • Beauty Health Company has entered a definitive agreement to acquire SkinStylus.
  • Upon the successful integration of SkinStylus into the BeautyHealth portfolio, the company expects an upside from the acquisition in 2024 and beyond.
  • BeautyHealth intends to seek FDA clearance for additional indications and regulatory approvals in other markets outside of the US for the SkinStyus device.

2 Article(s) Remaining

Subscribe today for full access